https://www.live-feeds.com/feed/fda-panel-endorses-first-of-a-kind-cancer-blood-test-from-grailContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/fda-panel-endorses-first-of-a-kind-cancer-blood-test-from-grailhttps://www.live-feeds.com/feed/fda-panel-endorses-first-of-a-kind-cancer-blood-test-from-grail#u84057Fri, 25 Sep 2026 17:50:22 +0000An FDA advisory panel voted to recommend the Galleri multi-cancer early detection test from Grail for approval. The committee voted 7-2 that the benefits of the test outweigh its risks and 10-0 that the test is safe for its proposed use. However, the panel was divided on effectiveness, with a narrow 6-4 vote regarding whether the test works. The test is designed to detect early signs of more than 50 types of cancer before symptoms appear.Why it mattersEarly detection of cancer typically requires specific screenings for individual organs. A single blood test capable of identifying dozens of can